# US 2006/0154952 A1 · Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154952 A1
- Document ID: US20060154952A1
- Status: Published application
- Kind: A1
- Application number: 10/547,185
- Filed: 2004-03-16
- Published: 2006-07-13
- Earliest claimed: 2003-03-17
- Inventors: Henrietta Moore
- Web page: https://patentgrep.com/patent/US20060154952A1

## CPC

- A61K 31/445: Non condensed piperidines, e.g. piperocaine
- A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 7/10: Antioedematous agents; Diuretics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/04: Antipruritics
- A61P 17/10: Anti-acne agents
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/02: Immunomodulators
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to pharmaceutical compositions comprising in combination rapamycin or a rapamycin derivative and a compound of formula I, e.g. useful for the treatment of inflammatory and immunologically-mediated diseases, including autoimmune diseases.

## Claims

### Claim 1

Pharmaceutical composition comprising in combination rapamycin or a rapamycin derivative and a compound of formula
wherein either
R1 is a group (a) of formula
wherein
R5 is chloro, bromo, iodo or azido,
R6 is hydroxy or methoxy, and
R4 is hydroxy and there is a single bond in 10,11 position; or absent, and there is a double bond in 10,11 position
or
R1 is a group (b) or (c) of formula
wherein
R6 is as defined above, and
R4 is hydroxy and there is a single bond in 10,11 position,
R2 is oxo and there is a single bond in 23,24 position; optionally protected hydroxy and there is a single or double bond in 23,24 position; or absent and there is a double bond in 23,24 position;
R3 is methyl, ethyl, propyl or allyl.
beside at least one pharmaceutically acceptable excipient.

### Claim 2 (depends on 1)

Pharmaceutical composition of claim 1 wherein a compound of formula I is a compound of formula

### Claim 3 (depends on 1, 2)

Pharmaceutical composition of any one of claims 1 or 2, wherein the rapamycin derivative is a compound of formula
wherein
R1 is methyl or (C3-6)alkynyl,
R2 is H, —CH2—CH2—OH, 3-hydroxy-2-(hydroxymethyl)-2-methyl-propanoyl or tetrazolyl,
X is =O, (H,H) or (H,OH),
provided that R2 is other than H when X is =O and R1 is CH3,
or a prodrug thereof when R2 is —CH2—CH2—OH.

### Claim 4 (depends on 1, 2, 3)

Pharmaceutical composition of any one of claims 1 to 3 comprising in combination 40-O-(2-hydroxyethyl)-rapamycin and pimecrolimus.

### Claim 5 (depends on 1, 2, 3, 4)

Pharmaceutical composition according to any one of claims 1 to 4 in the form of a solid dispersion comprising in combination rapamycin or a rapamycin derivative, a compound of formula I and a carrier.

### Claim 6

Pharmaceutical kit of parts comprising in combination rapamycin or a rapamycin derivative and a compound of formula I beside instructions for simultaneous or sequential administration.

### Claim 7

Use of a combination of rapamycin or a rapamycin derivative and a compound of formula I as a pharmaceutical.

### Claim 8

Use of a combination of rapamycin or a rapamycin derivative and a compound of formula I for the manufacture of a medicament for the treatment of inflammatory bowel disease and diseases associated therewith.

### Claim 9

Use of a combination of rapamycin or a rapamycin derivative and a compound of formula I for the manufacture of a medicament for the treatment of a disease selected from the group consisting of atopic dermatitis, contact dermatitis and further eczematous dermatoses, seborrhoeic dermatitis, contact hypersensitivity, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythemas, cutaneous eosinophilias and acne.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6)

A method for treatment of an inflammatory disease or an immunologically-mediated disease, including an autoimmune disease, which treatment comprises administering to a subject in need of such treatment an effective amount of a pharmaceutical composition of any one of claims 1 to 5 or of a pharmaceutical kit of parts of claim 6.

### Claim 11 (depends on 10)

A method of claim 10, wherein the disease is selected from the group consisting of atopic dermatitis, contact dermatitis and further eczematous dermatoses, seborrhoeic dermatitis, contact hypersensitivity, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythemas, cutaneous eosinophilias and acne.

### Claim 12 (depends on 10)

A method of claim 10, wherein the disease is inflammatory bowel disease and diseases associated therewith.

### Claim 13

Use of a combination of rapamycin or a rapamycin derivative and a compound of formula
wherein
R1 is hydroxy or protected hydroxy,
R2 is hydrogen, hydroxyl or protected hydroxyl,
R3 is methyl, ethyl, propyl or allyl,
n is an integer of 1 or 2, and
the symbol of a line and dotted line is a single bond for the manufacture of a medicament for the treatment of a disease selected from the group consisting of atopic dermatitis, contact dermatitis and further eczematous dermatoses, seborrhoeic dermatitis, contact hypersensitivity, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythemas, cutaneous eosinophilias and acne.

### Claim 14

Use of a combination of rapamycin or a rapamycin derivative and a compound of formula III for the manufacture of a medicament for the treatment of inflammatory bowel disease and diseases associated therewith.

### Claim 15 (depends on 13, 14)

Use of any one of claims 13 or 14 wherein a compound of formula III is a compound of formula

### Claim 16

Use of a compound of formula
wherein
R1 is methyl or (C3-6)alkynyl,
R2 is H, —CH2—CH2—OH, 3-hydroxy-2-(hydroxymethyl)-2-methyl-propanoyl or tetrazolyl,
X is =O, (H,H) or (H,OH),
provided that R2 is other than H when X is =O and R1 is CH3,
or a prodrug thereof when R2 is —CH2—CH2—OH for the manufacture of a medicament for the treatment of atopic dermatitis, contact dermatitis and further eczematous dermatoses, seborrhoeic dermatitis, contact hypersensitivity, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasculitides, erythemas, cutaneous eosinophilias and acne.

### Claim 17 (depends on 16)

Use of claim 16, wherein the compound of formula II is 40-O-(2-hydroxyethyl)-rapamycin.
